Literature DB >> 23061773

Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas.

Rajeev Kasaliwal1, Shilpa S Sankhe, Anurag R Lila, Sweta R Budyal, Varsha S Jagtap, Vijaya Sarathi, Harshal Kakade, Tushar Bandgar, Padmavathy S Menon, Nalini S Shah.   

Abstract

BACKGROUND: Various techniques have been attempted to increase the yield of magnetic resonance imaging (MRI) for localization of pituitary microadenomas in corticotropin (ACTH)-dependent Cushing's syndrome (CS).
OBJECTIVE: To compare the performance of dynamic contrast spin echo (DC-SE) and volume interpolated 3D-spoiled gradient echo (VI-SGE) MR sequences in the diagnostic evaluation of ACTH-dependent CS.
DESIGN: Data was analysed retrospectively from a series of ACTH-dependent CS patients treated over 2-year period at a tertiary care referral centre (2009-2011). PATIENTS: Thirty-six patients (24 female and 12 male) were diagnosed to have ACTH-dependent CS during the study period. All patients underwent MRI by both sequences during a single examination. Cases with negative and equivocal pituitary MR imaging underwent corticotropin-releasing hormone (CRH) stimulated bilateral inferior petrosal sinus sampling (BIPSS) to confirm pituitary origin of ACTH excess state. Thirty patients were finally diagnosed to have Cushing's disease (CD) [based on histopathology proof of adenoma and/or remission (partial/complete) of hypercortisolism postsurgery]. Six patients were diagnosed to have histopathologically proven ectopic CS.
RESULTS: Of 30 patients with CD, 24 patients had microadenomas and 6 patients had macroadenomas. DC-SE MRI sequence was able to identify microadenomas in 16 of 24 patients, whereas postcontrast VI-SGE sequence was able to identify microadenomas in 21 of 24 patients. All six patients of ectopic CS had negative pituitary MR imaging by both techniques (specificity: 100%).
CONCLUSION: VI-SGE MR sequence was better for localization of pituitary microadenomas particularly when DC-SE MR sequence is negative or equivocal and should be used in addition to DC-SE MR sequence for the evaluation of ACTH-dependent CS.
© 2012 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23061773     DOI: 10.1111/cen.12069

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  16 in total

Review 1.  Pituitary magnetic resonance imaging in Cushing's disease.

Authors:  Giovanni Vitale; Fabio Tortora; Roberto Baldelli; Francesco Cocchiara; Rosa Maria Paragliola; Emilia Sbardella; Chiara Simeoli; Ferdinando Caranci; Rosario Pivonello; Annamaria Colao
Journal:  Endocrine       Date:  2016-07-19       Impact factor: 3.633

Review 2.  Surgical management of Cushing's disease.

Authors:  Robert F Dallapiazza; Edward H Oldfield; John A Jane
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

Review 3.  State of art imaging of the pituitary tumors.

Authors:  Nicholas J Patronas; Chia-Ying Liu
Journal:  J Neurooncol       Date:  2013-12-17       Impact factor: 4.130

Review 4.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

5.  Pituitary-Targeted Dynamic Contrast-Enhanced Multisection CT for Detecting MR Imaging-Occult Functional Pituitary Microadenoma.

Authors:  M Kinoshita; H Tanaka; H Arita; Y Goto; S Oshino; Y Watanabe; T Yoshimine; Y Saitoh
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

6.  High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.

Authors:  Prashant Chittiboina; Blake K Montgomery; Corina Millo; Peter Herscovitch; Russell R Lonser
Journal:  J Neurosurg       Date:  2014-12-05       Impact factor: 5.115

7.  CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease.

Authors:  Jacqueline Boyle; Nicholas J Patronas; James Smirniotopoulos; Peter Herscovitch; William Dieckman; Corina Millo; Dragan Maric; Grégoire P Chatain; Christina Piper Hayes; Sarah Benzo; Gretchen Scott; Nancy Edwards; Abhik Ray Chaudhury; Maya B Lodish; Susmeeta Sharma; Lynnette K Nieman; Constantine A Stratakis; Russell R Lonser; Prashant Chittiboina
Journal:  Endocrine       Date:  2019-05-06       Impact factor: 3.633

8.  Endosphenoidal coil for intraoperative magnetic resonance imaging of the pituitary gland during transsphenoidal surgery.

Authors:  Prashant Chittiboina; S Lalith Talagala; Hellmut Merkle; Joelle E Sarlls; Blake K Montgomery; Martin G Piazza; Gretchen Scott; Abhik Ray-Chaudhury; Russell R Lonser; Edward H Oldfield; Alan P Koretsky; John A Butman
Journal:  J Neurosurg       Date:  2016-03-18       Impact factor: 5.115

9.  Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1.

Authors:  Jie Lu; Blake K Montgomery; Grégoire P Chatain; Alejandro Bugarini; Qi Zhang; Xiang Wang; Nancy A Edwards; Abhik Ray-Chaudhury; Marsha J Merrill; Russell R Lonser; Prashant Chittiboina
Journal:  Mol Cell Endocrinol       Date:  2017-10-03       Impact factor: 4.102

10.  Potential utility of FLAIR in MRI-negative Cushing's disease.

Authors:  Grégoire P Chatain; Nicholas Patronas; James G Smirniotopoulos; Martin Piazza; Sarah Benzo; Abhik Ray-Chaudhury; Susmeeta Sharma; Maya Lodish; Lynnette Nieman; Constantine A Stratakis; Prashant Chittiboina
Journal:  J Neurosurg       Date:  2017-10-13       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.